Anthony S. Wierzbicki

Citované v

	Všetky	Od 2020
Citácie	16542	4311
h-index	65	31
i10-index	243	96

1000

500

250

750

19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202564 118 178 177 330 314 389 453 510 558 543 594 660 735 857 886 837 989 935 853 893 893 921 793 826 742 130

Verejný prístup

všetky položky

23 článkov

6 článkov

dostupné

nedostupné

Na základe mandátov na financovanie

Spoluautori

Tim ReynoldsProfessor of Chemical Pathology, Queen's Hospital, Burton-on-Trent, UKOverená e-mailová adresa na: ynolds.org.uk
Tim HardmanNiche Science & Technology LtdOverená e-mailová adresa na: niche.org.uk
michael feherVisiting ProfessorOverená e-mailová adresa na: londonfeher.com
Samuel GiddingA. I. duPont Hospital for ChildrenOverená e-mailová adresa na: nemours.org
Matthew D. LloydSenior Lecturer (Associate Professor) of Pharmacy & Pharmacology, University of Bath, United KingdomOverená e-mailová adresa na: bath.ac.uk
Raul D. SantosHospital Israelita Albert Einstein and University of Sao Paulo School of MedicineOverená e-mailová adresa na: incor.usp.br
G HampsonGuy's and St. Thomas' NHS Foundation TrustOverená e-mailová adresa na: kcl.ac.uk
F J RaalProfessor, University of the WitwatersrandOverená e-mailová adresa na: wits.ac.za
Emanuel ChristProfessor of Endocrinology, University Hospital of BaselOverená e-mailová adresa na: usb.ch
David GoldsmithEmeritus Guy's and St Thomas' Hospitals NHS Foundation TrustOverená e-mailová adresa na: solascure.com
Handrean SoranManchester University NHS Foundation TrustOverená e-mailová adresa na: mft.nhs.uk
Athyros VEmeritus Professor of Internal Medicine Aristotelian University, Thessaloniki, GreeceOverená e-mailová adresa na: med.auth.gr
William Virgil BrownNational Lipid AssociationOverená e-mailová adresa na: lipid.org
Peter P. Toth, MD, PhD, FAHA, FESC,...Adjunct Professor of Medicine, Division of Cardiology, Johns Hopkins University School of MedicineOverená e-mailová adresa na: jhmi.edu
Nadia Jean KershawWalter and Eliza Hall InstituteOverená e-mailová adresa na: wehi.edu.au
Joshua W. KnowlesAssistant Professor, StanfordOverená e-mailová adresa na: stanford.edu
Sarah de FerrantiAssociate Professor of Pediatric Cardiology, Boston Children's HospitalOverená e-mailová adresa na: cardio.chboston.org
Michael MarberProfessor of CardiologyOverená e-mailová adresa na: kcl.ac.uk
Paul DurringtonProfessor of Medicine, University of ManchesterOverená e-mailová adresa na: manchester.ac.uk
David R SullivanClinical Associate Professor, University of SydneyOverená e-mailová adresa na: sydney.edu.au

Sledovať

Anthony S. Wierzbicki

Consultant (Honorary Professor) in Metabolic Medicine, Guy's & St Thomas' Hospitals London UK

Overená e-mailová adresa na: kcl.ac.uk

Cholesterol triglyceride lipids cardiovascular risk peroxisome


Názov Zoradiť podľa citácií Zoradiť podľa roka Zoradiť podľa názvu	Citované v Citované v	Rok
The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association SS Gidding, M Ann Champagne, SD de Ferranti, J Defesche, MK Ito, ... Circulation 132 (22), 2167-2192, 2015	701	2015
Familial hypercholesterolaemia JC Defesche, SS Gidding, M Harada-Shiba, RA Hegele, RD Santos, ... Nature reviews Disease primers 3 (1), 1-20, 2017	609	2017
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... International journal of cardiology 171 (3), 309-325, 2014	602	2014
Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial. J Armitage, L Bowman, K Wallendszus, R Bulbulia, K Rahimi, R Haynes, ... Lancet (London, England) 376 (9753), 2010	546	2010
Homocysteine and cardiovascular disease: a review of the evidence AS Wierzbicki Diabetes and Vascular Disease Research 4 (2), 143-149, 2007	414	2007
The lipid and non-lipid effects of statins AS Wierzbicki, R Poston, A Ferro Pharmacology & therapeutics 99 (1), 95-112, 2003	358	2003
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance S Rabar, M Harker, N O’Flynn, AS Wierzbicki Bmj 349, 2014	342	2014
“European panel on low density lipoprotein (LDL) subclasses”: a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses D P Mikhailidis, M Elisaf, M Rizzo, K Berneis, B Griffin, A Zambon, ... Current vascular pharmacology 9 (5), 533-571, 2011	328	2011
Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4α mutations in a large European collection ER Pearson, S Pruhova, CJ Tack, A Johansen, HAJ Castleden, PJ Lumb, ... Diabetologia 48, 878-885, 2005	309	2005
Familial hypercholesterolaemia: summary of NICE guidance AS Wierzbicki, SE Humphries, R Minhas Bmj 337, 2008	294	2008
Relation of erectile dysfunction to angiographic coronary artery disease H Solomon, JW Man, AS Wierzbicki, G Jackson American Journal of Cardiology 91 (2), 230-231, 2003	281	2003
Multiple actions of high-density lipoprotein M Florentin, EN Liberopoulos, AS Wierzbicki, DP Mikhailidis Current opinion in cardiology 23 (4), 370-378, 2008	279	2008
Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial T Marteau, V Senior, SE Humphries, M Bobrow, T Cranston, MA Crook, ... American journal of medical genetics Part A 128 (3), 285-293, 2004	229	2004
Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation AS Wierzbicki, MD Lloyd, CJ Schofield, MD Feher, FB Gibberd Journal of neurochemistry 80 (5), 727-735, 2002	226	2002
Statin-fibrate combination therapy for hyperlipidaemia: a review AS Wierzbicki, DP Mikhailidis, R Wray, M Schachter, R Cramb, ... Current medical research and opinion 19 (3), 155-168, 2003	212	2003
Identification of PEX7 as the second gene involved in Refsum disease DM Van Den Brink, P Brites, J Haasjes, AS Wierzbicki, J Mitchell, ... The American Journal of Human Genetics 72 (2), 471-477, 2003	200	2003
Polymorphisms in the P450 c17 (17-hydroxylase/17, 20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in … J Somner, S McLellan, J Cheung, YT Mak, ML Frost, KM Knapp, ... The Journal of Clinical Endocrinology & Metabolism 89 (1), 344-351, 2004	157	2004
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation GF Watts, S Gidding, AS Wierzbicki, PP Toth, R Alonso, WV Brown, ... Journal of Clinical Lipidology 8 (2), 148-172, 2014	156	2014
α‐Methylacyl‐CoA racemase–an ‘obscure’metabolic enzyme takes centre stage MD Lloyd, DJ Darley, AS Wierzbicki, MD Threadgill The FEBS journal 275 (6), 1089-1102, 2008	156	2008
American heart association atherosclerosis, hypertension, and obesity in young committee of council on cardiovascular disease in young, council on cardiovascular and stroke … SS Gidding, MA Champagne, SD De Ferranti, J Defesche, MK Ito, ... Circulation 132 (22), 2167-2192, 2015	154	2015

Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.

Články 1–20

Citácie za rok

Duplicitné citácie

Zlúčené citácie

Pridať spoluautorovSpoluautori

Sledovať

Citované v

Spoluautori